Suppression of experimental autoimmune myasthenia gravis by intravenous immunoglobulin and isolation of a disease-specific IgG fraction

Keyphrases

• Anti-idiotypic 33%
• Antigen-specific 33%
• Autoimmune Disease 33%
• Cell-to-cell 33%
• Chromatography 33%
• Disease-specific 100%
• Eluate 33%
• Experimental Autoimmune 66%
• Experimental Autoimmune Myasthenia Gravis 100%
• Immunoglobulin 33%
• Immunosuppressive Activity 33%
• Intravenous Immunoglobulin (IVIg) 100%
• Intravenous Immunoglobulin Therapy 66%
• Myasthenia Gravis 33%
• Pooled Human Immunoglobulin 33%
• Serum IgE 100%
• Specific Antibodies 33%
• Study Support 33%
• Suppressive Activity 66%
• Th1 Cells 33%
• Therapeutic Effect 33%
• β-cell Proliferation 33%

Immunology and Microbiology

• Antigen Specificity 20%
• Autoimmune Disease 20%
• B Cell 20%
• Cell Proliferation 20%
• Chromatography 20%
• Experimental Autoimmune Myasthenia Gravis 100%
• Human Immunoglobulin 20%
• Immunoglobulin Antibody 20%
• Immunosuppressive Drug 20%
• Intravenous Immunoglobulin 100%
• Monospecific Antibody 20%
• Myasthenia gravis 20%
• Th1 Cell 20%